The file's text, extracted by GovTribe without its formatting.
Special Notice Special Notice
| SUBJECT* |
| Notice of Intent to Sole Source Amarillo VAHCS Blood Support Services |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 78240 |
| SOLICITATION NUMBER* |
| 36C25725Q0597 |
| RESPONSE DATE/TIME/ZONE |
| 05-29-2025 13:00 EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 30 DAYS AFTER THE RESPONSE DATE |
| PRODUCT SERVICE CODE* |
| 6505 |
| CONTRACTING OFFICE ADDRESS |
| Department of Veterans Affairs |
Network Contracting Office 17 5441 Babcock Road, Ste. 302
El Paso TX 79936-4221
POINT OF CONTACT*
Contract Specialist Joshua Weisman joshua.weisman@va.gov 915-838-6452
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
AGENCY CONTACT’S EMAIL ADDRESS
EMAIL DESCRIPTION
DESCRIPTION
Special Notice – Notice of Intent to Award a Sole Source Procurement
The Thomas E. Creek VA Health Care System located in Amarillo, Texas has an ongoing need for the supply of blood and blood products from the Oklahoma Blood Institute (OBI). The activity requires a continuous source for various transfusions as well as services related to transfusion screening services on a daily and 24/7 emergency basis.
The names and/or description of the supplies are included at the bottom of this document.
Delivery Address:
Department of Veterans Affairs Amarillo VAHCS 6010 Amarillo Blvd West Amarillo, TX 79106-1991
The proposed sole source procurement will be made by an Indefinite Delivery Indefinite Quantity (IDIA) contract with the Oklahoma Blood Institute (OBI).
The requesting activity has submitted a sole source justification request that states that vendor is the only vendor that can provide the necessary products and services to be a direct replacement of the currently provided blood products. Market research has not found an alternate approved vendor that can provide all the required linearity supplies for the services.
This notice is not to be considered a request for quotations or proposals. No contract will be awarded on the basis of offers received in response to this notice; however, all responsible sources may submit a capability statement, proposal or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 5 days from the publication of this notice, a contract will be issued to CAP without any further notice.
The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
| DESCRIPTION |
| ANNUAL ESTIMATES |
| 01A: ABO/Rh (per specimen) |
| 11 |
| 02A: Direct Antiglobulin Test (Coombs Test) - single |
| 11 |
| 04A: Cold agglutinin low temperature screen |
| 11 |
| 04B: Antibody Elution and Red Cell Panel |
| 11 |
| 04E: Antibody Absorption and Red Cell Panel |
| 11 |
| 04F: Additional Red Cell Antibody Panel |
| 11 |
| 11: Washing (per unit) - RBC |
| 1 |
| 12: Freezing/Deglycerolization (per unit) |
| 1 |
| 12B: Compatibility Testing (per unit) - AHG |
| 20 |
| 14: CMV Negative Blood Product (Available Inventory) |
| 1 |
| 15A: Fetal Hemoglobin Screen (rosette test) |
| 1 |
| 16B: Leukoreduced Red Blood Cells |
| 200 |
| 16I: Leukoreduced Red Blood Cells - Irradiated |
| 11 |
| 34: Washing (per unit) - Platelet - plus plasma |
| 1 |
| 34A: Washing (per unit) - Platelet - plus plasma-A |
| 1 |
| 40: AFFP ( 250 + 25ml) x 2 Apheresis Derived |
| 1 |
| 40-2: AFFP ( 250 + 25ml) x 1 Apheresis Derived |
| 11 |
| 40CCP: COVID-19 Convalescent Plasma, (CCP) ~200 ml dose, High Titer |
| 1 |
| 40PED: AFFP (100 + 10ml) x 1 Apheresis Derived |
| 1 |
| 42: FFP-WBD 1 x 250ml (250 + 25 ml) Whole Blood Derived |
| 1 |
| 42HR: FP-24 (Frozen < 24 hours) 1 x 250ml (250 + 25ml) |
| 11 |
| 42PED: FP-24 (Frozen < 24 hours) 1 x 100ml (100 + 10 ml) |
| 1 |
| 44: Cryoprecipitated AHF |
| 1 |
| 44PD: Cryoprecipitate Pool of 5 (includes pooling fee) |
| 11 |
| 44PD10: Cryoprecipitate Pool of 10 (includes pooling fee) |
| 1 |
| 61: Leukoreduced Apheresis Platelets |
| 20 |
| 61I: Leukoreduced Apheresis Platelets - Irradiated |
| 11 |
| 96: Autologous Collection (per component) |
| 1 |
| 97: Directed Collection (per component) |
| 1 |
| 99C: Aliquot Bags, Pediatric (attached, per set) |
| 1 |
| EXT: Extraction of DNA for red cell phenotype by molecular method |
| 10 |
| FC10: Pooled Fibrinogen Complex 1.0, Psoralen Treated - 740 mg Fibrinogen (mean) |
| 1 |
| FC15: Pooled Fibrinogen Complex 1.5, Psoralen Treated - 1,457 mg Fibrinogen (mean |
| 1 |
| FC20: Pooled Fibrinogen Complex 2.0, Psoralen Treated - 2,220 mg Fibrinogen (mean) |
| 1 |
| FC30: Pooled Fibrinogen Complex 3.0, Psoralen Treated - 3,117 mg Fibrinogen (mean) |
| 1 |
| FC40: Pooled Fibrinogen Complex 4.0, Psoralen Treated - 3,700 mg Fibrinogen (mean) |
| 1 |
| L04: Antibody Identification (includes ABO/Rh, antibody screen, comprehensive DAT, red cell panel, written consultation report, medical consultation as needed.) |
| 11 |
| L08: After hours Tech call Fee: Surcharge per patient request |
| 11 |
| DESCRIPTION |
| ANNUAL ESTIMATES |
| L12: Compatibility Testing (per unit) - Immediate Spin |
| 1 |
| L13: Pretreatment of Serum (eg. DTT, Rest, Plasma Neutralization, Urine Inhibition, Lewis Neutralization, P1 Neutralization) |
| 1 |
| L14: Pretreatment of RBCs (eg. DTT, CDP, EGA, Ficin, Density Gradient Separation, Neocytes) |
| 11 |
| L15: Fetal Hemoglobin Stain (Kliehauer Betke) |
| 1 |
L30: Blood Component Preparation for each order to cover the preparation of the blood component for transport and transfusion.
| L31: Sample resubmission |
| 1 |
| L32: Cancellation Fee charged when an order is cancelled once a driver is dispatched. |
| 1 |
| L35: Shipping Fee - Specimen Transport or Reagents Shipped Without Blood |
| 1 |
| L89: Sickle Cell Testing (per unit) |
| 1 |
| LVDS: Platelet Large Volume Delayed Sampling Fee |
| 11 |
End of Document
End of Document
| *= Required Field |
| Special Notice |
Special Notice
